Valuation : Viatris Inc.

Market Cap 18.95B 16.33B 15.41B 14.03B 26.22B 1,809B 26.48B 183B 70.51B 920B 71.16B 69.61B 2,926B P/E 2026 *
77.8x
P/E 2027 * 30.9x
Enterprise Value 31.02B 26.72B 25.22B 22.96B 42.91B 2,960B 43.34B 300B 115B 1,506B 116B 114B 4,789B EV / Sales 2026 *
2.1x
EV / Sales 2027 * 1.99x
Free-Float
91.44%
Yield 2026 *
3.11%
Yield 2027 * 3.19%
1 day-0.73%
1 week-4.15%
Current month-0.79%
1 month-0.30%
3 months+1.11%
6 months+15.19%
Current year+31.57%
1 week 16.15
Extreme 16.15
17.02
1 month 15.88
Extreme 15.88
17.28
Current year 12.19
Extreme 12.19
18.39
1 year 9.42
Extreme 9.425
18.39
3 years 6.85
Extreme 6.85
18.39
5 years 6.85
Extreme 6.85
18.39
10 years 6.85
Extreme 6.85
47.82
Manager TitleAgeSince
Chief Executive Officer 63 01/04/2023
Director of Finance/CFO 59 08/05/2026
Chief Tech/Sci/R&D Officer - 15/12/2023
Director TitleAgeSince
Director/Board Member 78 16/11/2020
Director/Board Member 78 16/11/2020
Director/Board Member 62 16/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
8/15/26 A Exercice

Chief Administrative Officer

63,631 0.0054%
6/30/26 A Free

Director

2,756 0.0002%
6/30/26 A Free

Director

2,362 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.73%-4.15%+56.75%+62.02% 18.95B
-0.11%-3.20%+49.61%+91.49% 1,002B
-0.27%-3.22%+50.51%+65.89% 644B
+1.63%-2.57%+21.19%+71.12% 443B
-0.63%-1.06%+28.11%+34.59% 343B
+0.43%-14.61%+9.88%+27.26% 262B
+0.93%-1.82%-1.82%+8.41% 245B
-2.25%-13.63%+36.61%+47.43% 212B
-0.90%-5.09%-15.47%-57.75% 199B
-0.58%-3.21%+25.10%+90.54% 181B
Average +0.01%-4.84%+26.05%+44.10% 354.86B
Weighted average by Cap. +0.28%-4.24%+32.04%+57.14%

Financials

2026 *2027 *
Net sales 14.79B 12.74B 12.02B 10.94B 20.46B 1,411B 20.66B 143B 55.01B 718B 55.52B 54.31B 2,283B 15.06B 12.97B 12.24B 11.15B 20.83B 1,437B 21.04B 146B 56.03B 731B 56.55B 55.31B 2,325B
Net income -27.26M -23.48M -22.16M -20.17M -37.71M -2.6B -38.08M -264M -101M -1.32B -102M -100M -4.21B 340M 293M 276M 252M 470M 32.44B 475M 3.29B 1.26B 16.5B 1.28B 1.25B 52.48B
Net Debt 12.07B 10.39B 9.81B 8.93B 16.69B 1,151B 16.86B 117B 44.89B 586B 45.3B 44.31B 1,863B 11.08B 9.54B 9.01B 8.2B 15.33B 1,057B 15.48B 107B 41.22B 538B 41.6B 40.69B 1,711B
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.
Employees
30,000
Date Price Change Volume
10/09/26 $16.38 -0.73% 9,005,878
09/09/26 $16.50 -0.66% 6,510,509
08/09/26 $16.61 -1.60% 4,394,622
04/09/26 $16.88 -0.35% 5,732,791
03/09/26 $16.94 -0.88% 8,032,034
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
16.38USD
Average target price
18.67USD
Spread / Average Target
+13.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VTRS Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!